2011
DOI: 10.1182/blood-2011-01-329052
|View full text |Cite
|
Sign up to set email alerts
|

Idiopathic CD4+ T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations

Abstract: A girl presented during childhood with a single course of extensive chickenpox and moderate albeit recurrent pneumonia in the presence of idiopathic CD4 ؉ T lymphocytopenia (ICL). Her clinical condition remained stable over the past 10 years without infections, any granulomatous disease, or autoimmunity. Immunophenotyping demonstrated strongly reduced naive T and B cells with intact proliferative capacity. Antibody reactivity on in vivo immunizations was normal. T-cell receptor-V␤ repertoire was polyclonal wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
68
0
1

Year Published

2012
2012
2021
2021

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 100 publications
(70 citation statements)
references
References 22 publications
1
68
0
1
Order By: Relevance
“…1,2 ICL is most frequently diagnosed in adults, although pediatric cases have been reported. [2][3][4][5] Patients may show opportunistic infections as a result of a profound deficiency in cellmediated immune responses. 2,6,7 Although the molecular mechanisms underlying this heterogeneous syndrome are still unclear, loss-offunction mutations have been described for genes encoding various regulators of T-cell receptor (TCR) diversity and signaling.…”
Section: Introductionmentioning
confidence: 99%
“…1,2 ICL is most frequently diagnosed in adults, although pediatric cases have been reported. [2][3][4][5] Patients may show opportunistic infections as a result of a profound deficiency in cellmediated immune responses. 2,6,7 Although the molecular mechanisms underlying this heterogeneous syndrome are still unclear, loss-offunction mutations have been described for genes encoding various regulators of T-cell receptor (TCR) diversity and signaling.…”
Section: Introductionmentioning
confidence: 99%
“…This is best illustrated by RAG (recombination activating gene) mutations, which produce variable immune defects. 8,28,29 Complete RAG deficiency with no (Ͻ 1% of wild type) recombination activity is associated with classic SCID and absence of T and B cells. In RAG deficiency with minimal residual activity (Ͼ 1% recombination activity of wild type), several clinical and immunologic phenotypes have been described: (1) classic Omenn syndrome with skin inflammation and ␣-␤ T-cell expansion; (2) incomplete Omenn syndrome with skin inflammation and without T-cell expansion; (3) RAG deficiency with ␥-␦ T-cell expansion; (4) RAG deficiency with granulomas; and (5) ICL.…”
Section: Discussionmentioning
confidence: 99%
“…The described patients had defects in the magnesium transporter gene (MAGT1) or the recombination activating gene 1 (RAG1). 7,8 Here we characterize a mutation in the Unc119 gene as a novel genetic defect in ICL. Unc119 is a signaling adaptor protein which is essential for activation of the key T-cell tyrosine kinase Lck.…”
Section: Introductionmentioning
confidence: 99%
“…3 In an immunodeficiency syndrome featuring warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM), mutations of the chemokine receptor CXCR4 leading to neutropenia and immunodeficiency were recognized. 4 Other possible mechanisms proposed in the pathogenesis of ICL have been suggested to be in the Fas & Fas ligand, 5 enhanced apoptotic deletion of T-cells, 6 defective thymic maturation of T-cells, 7 reduction in the p56 (Lck) kinase activity, 8 reduced responsiveness of the circulating Tcells to IL-7 (may be due to IL-7 receptor defect), 9 RAG1 & RAG2 gene mutations, 10 a defect in the MAGT 1 (magnesium transporter gene), 11 defective production of TNF-alpha & IFN-gamma, 12 and a heterozygous dominant negative mis-sense mutation of the signalling adaptor protein Uncoordinated 119 (Unc119) that disrupts the association between Lck (lymphocyte specific kinase) and TCR (T-cell receptor). 13 Currently there are no definite treatment options for this novel condition and treatment is generally aimed at preventing infections and malignancies by prophylactic antibiotics and medications as used in a case of HIV infected patient.…”
Section: Disscusionmentioning
confidence: 99%